ライフサイエンスコーパス: polymyalgia rheumatica

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ases, infections, and malignancies can mimic polymyalgia rheumatica.

2 ases in acute phase reactants are typical of polymyalgia rheumatica.

3 Several other disorders can mimic polymyalgia rheumatica.

4 GCA relapse heralded by symptoms of isolated polymyalgia rheumatica (1 case versus 5 in the placebo g

5 timate of 21 million for 1995), 711,000 have polymyalgia rheumatica, 228,000 have giant cell arteriti

6 toms and clinical features characteristic of polymyalgia rheumatica and/or giant cell arteritis (GCA)

7 nifestations are headache, jaw claudication, polymyalgia rheumatica, and visual symptoms.

8 This issue provides a clinical overview of polymyalgia rheumatica, focusing on risk factors, diagno

9 Polymyalgia rheumatica is a chronic, inflammatory disord

10 Polymyalgia rheumatica is an inflammatory disease that a

11 val (CI): 1.1-1.2), P=9.8 x 10(-11)) and for polymyalgia rheumatica near C6orf10 at rs6910071 (OR=1.5

12 Polymyalgia rheumatica occurred with similar frequency i

13 Polymyalgia rheumatica (PMR) and giant cell arteritis (G

14 Polymyalgia rheumatica (PMR) has an abrupt onset of infl

15 omic basis for joint disease localization in polymyalgia rheumatica (PMR) is poorly understood.

16 To evaluate the impact of polymyalgia rheumatica (PMR) on clinical outcomes and qu

17 Imaging studies in GCA and polymyalgia rheumatica (PMR) suggest that vasculitis can

18 In patients with polymyalgia rheumatica (PMR), a subclinical variant of G

19 /or visual abnormalities, fever, concomitant polymyalgia rheumatica (PMR), and histologic evidence of

20 nifestations are headache, jaw claudication, polymyalgia rheumatica (PMR), and visual symptoms, but 4

21 ic lupus erythematosus, psoriatic arthritis, polymyalgia rheumatica (PMR), giant cell arteritis, anky

22 ous cardiovascular diseases in patients with polymyalgia rheumatica (PMR).

23 of Rheumatology classification criteria for polymyalgia rheumatica (PMR).

24 such as anti-interleukin 6, in patients with polymyalgia rheumatica that is refractory to glucocortic

25 One patient with polymyalgia rheumatica who developed the inhibitor while

26 with nonstenosing vasculitis; and "isolated" polymyalgia rheumatica with myalgias, systemic inflammat

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。